Recurrent or Progressive High Grade Meningioma

1

Review clinical trials related to Recurrent or Progressive High Grade Meningioma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade Meningioma

This is a randomized, controlled, open-label, multicenter, Phase II clinical study designed to evaluate the efficacy and safety of SYHA1813 compared to investigators' choice in participants with recurrent or progressive high-grade meningioma.

Participants needed: 56
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Runshi Pharmaceutical Technology Co., LtdUpdated: Dec 18, 2024
Eligibility criteria

Aged >= 18 years; [+5]

Patients who are known or suspected to be allergic to the test drug or its compo... [+19]